Literature DB >> 8459973

Perioperative complications arising after transvaginal oocyte retrieval.

R W Tureck1, C R García, L Blasco, L Mastroianni.   

Abstract

OBJECTIVE: To determine the incidence of perioperative morbidity in patients undergoing transvaginal oocyte retrieval and to identify those patients at greatest risk for complications.
METHODS: A retrospective analysis was performed on 674 patients of reproductive age who underwent transvaginal retrieval of oocytes for assisted reproduction technologies during a 3-year period. All procedures were performed by surgeons with extensive experience with transvaginal retrieval. Patients were entered into the program with a primary diagnosis of unexplained infertility (16%), endometriosis (32%), pelvic adhesions and/or tubal occlusion (38%), or infertility from male or immunologic factors (14%).
RESULTS: Of the 674 patients studied, ten (1.5%) required hospital admission because of perioperative complications. Nine of these patients needed intravenous antibiotics and one required admission and observation for an expanding broad-ligament hematoma. Six of nine women admitted for antibiotic therapy had a history of extensive pelvic adhesions with or without a history of salpingitis. Five of nine patients had a history of salpingitis. In addition, two patients experienced impressive vaginal arterial bleeding during the procedure.
CONCLUSION: This study suggests that transvaginal retrieval may not be as innocuous as is often expressed and that the primary factor predisposing to perioperative morbidity is a history of previous pelvic inflammatory disease and/or adnexal adhesions.

Entities:  

Mesh:

Year:  1993        PMID: 8459973

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  8 in total

1.  Severe intraabdominal bleeding after transvaginal oocyte retrieval for IVF-ET and coagulation factor XI deficiency: a case report.

Authors:  C Battaglia; G Regnani; S Giulini; L Madgar; A D Genazzani; A Volpe
Journal:  J Assist Reprod Genet       Date:  2001-03       Impact factor: 3.412

2.  VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Shannon M Bates; Ian A Greer; Saskia Middeldorp; David L Veenstra; Anne-Marie Prabulos; Per Olav Vandvik
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Actinomyces urogenitalis bacteremia and tubo-ovarian abscess after an in vitro fertilization (IVF) procedure.

Authors:  Frederik Van Hoecke; Ellen Beuckelaers; Peter Lissens; Michael Boudewijns
Journal:  J Clin Microbiol       Date:  2013-09-11       Impact factor: 5.948

4.  A three step protocol for the treatment of idiopathic subfertility.

Authors:  F D Berg; V Seifert-Klauss; C Lauritzen; A Teschner; C Brucker
Journal:  Arch Gynecol Obstet       Date:  1994       Impact factor: 2.344

5.  Bilateral ovarian abscesses following transvaginal oocyte retrieval for IVF: a case report and review of literature.

Authors:  Ehab Kelada; Rauf Ghani
Journal:  J Assist Reprod Genet       Date:  2007-02-16       Impact factor: 3.412

6.  Minimizing the Risk of Infection and Bleeding at Trans-Vaginal Ultrasound-Guided Ovum Pick-up: Results of a Prospective Web-Based World-Wide Survey.

Authors:  Harish Bhandari; Rina Agrawal; Ariel Weissman; Gon Shoham; Milton Leong; Zeev Shoham
Journal:  J Obstet Gynaecol India       Date:  2014-11-08

7.  Impact of class III obesity on outcomes and complications of transvaginal ultrasound-guided oocyte pickup.

Authors:  Tina Liang; Kelsey Ruetz; Olga Haakman; Angelos Vilos; George Vilos; Basim Abu-Rafea
Journal:  F S Rep       Date:  2020-08-27

8.  Transvaginal oocyte retrieval complicated by life-threatening obturator artery haemorrhage and managed by a vessel-preserving technique.

Authors:  Ferdia Bolster; Edgar Mocanu; Tony Geoghegan; Leo Lawler
Journal:  Ulster Med J       Date:  2014-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.